Randomized Multicenter Phase II Study of Larotaxel (XRP9881) in Combination with Cisplatin or Gemcitabine as First-Line Chemotherapy in Nonirradiable Stage IIIB or Stage IV Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Randomized Multicenter Phase II Study of Larotaxel (XRP9881) in Combination with Cisplatin or Gemcitabine as First-Line Chemotherapy in Nonirradiable Stage IIIB or Stage IV Non-small Cell Lung Cancer

Published:2008-08 Issue:8 Volume:3 Page:894-901
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Zatloukal Petr,Gervais Radj,Vansteenkiste Johan,Bosquee Léon,Sessa Christiana,Brain Etienne,Dansin Eric,Urban Thierry,Dohollou Nadine,Besenval Michèle,Quoix Elisabeth

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Lung cancer: district active treatment rates affect survival;Cartman;J Epidemiol Community Health,2002

3. Prospective population-based study on the survival of patients with lung cancer;Makitaro;Eur Respir J,2002

4. American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

5. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non–small-cell lung cancer: a Southwest oncology group trial;Kelly;J Clin Oncol,2001

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer activity of natural compounds from stems/barks of the plants;Natural Products as Anticancer Agents;2024

2. HPLC separation, synthesis, isolation and characterization of process related and degradation impurities in larotaxel including method development and validation;Journal of Pharmaceutical and Biomedical Analysis;2023-09

3. The Progress of the Anticancer Agents Related to the Microtubules Target;Mini-Reviews in Medicinal Chemistry;2021-01-14

4. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics;Current Topics in Medicinal Chemistry;2019-07-30

5. Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials;Current Cancer Drug Targets;2017-04-18